ArticleBMC pulmonary medicine2025
The diagnostic value of combined pulmonary function test and exhaled nitric oxide monitoring in cough variant asthma with or without gastroesophageal reflux disease: a retrospective study.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Predictors of cough resolution following endoscopic minimally invasive treatment in patients with GERD and chronic cough: a retrospective study.Frontiers in medicine · 2026Article
- Correlation of IgE and FeNO with lung function in children with asthma: a retrospective study.BMC pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis study aimed to investigate the effect of fractional exhaled nitric oxide (FeNO), a marker of airway inflammation, together with small airway function tests in diagnosing cough variant asthma (CVA), particularly in patients with gastroesophageal reflux disease (GERD).
methodsThis retrospective cohort study included adult patients with chronic cough for more than eight weeks who were divided into a CVA group and a control group. Participants underwent pulmonary function tests and FeNO measurements. Statistical tests and ROC curve analysis were used to assess diagnostic accuracy.
resultsCVA patients had higher FeNO levels than controls, regardless of with or without GERD. There were no significant differences in FEV1, FVC, and FEV1/FVC ratio between the control and CVA groups, but CVA patients had significantly lower MEF25, MEF50, MEF75, and MMEF values. FeNO was negatively correlated with MEF50, MEF75, and MMEF. The AUC of FeNO in diagnosing CVA was 0.862. Combining FeNO with MMEF resulted in the highest diagnostic accuracy (AUC = 0.909). The diagnostic benefits of FeNO and FeNO + MMEF were similar in GERD patients.
conclusionCombining FeNO with small airway function tests, especially MMEF, can improve the diagnostic accuracy of CVA, while FeNO and FeNO + MMEF performed similar diagnostic accuracy in patients with GERD. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.